Systematic review of treatments for diabetic peripheral neuropathy

Diabetic Medicine

Volumn 33, Issue 11, 2016, Pages 1466-1476

  Cakici N ^a   Fakkel, T M ^a   van Neck, J W ^a   Verhagen, A P ^a   Coert, J H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BOTULINUM TOXIN A; MEXIDOL; THIOCTIC ACID; UNCLASSIFIED DRUG;

DIABETIC NEUROPATHY; DRUG DOSE REDUCTION; EMBASE; HUMAN; INTENTION TO TREAT ANALYSIS; MASSAGE; MEDLINE; META ANALYSIS; NEUROPATHIC PAIN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFLEXOLOGY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WEB OF SCIENCE; ALTERNATIVE MEDICINE; ANALGESIA; DIABETIC FOOT; NEURALGIA; PROCEDURES; STATISTICS AND NUMERICAL DATA;

COMPLEMENTARY THERAPIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; HUMANS; NEURALGIA; PAIN MANAGEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84958781210     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13083     Document Type: Review

References (37)

1. Diabetic Neuropathies: The Nerve Damage of Diabetes [article online], 2013. Available at http://diabetes.niddk.nih.gov/dm/pubs/neuropathies/ Last accessed 16 October 2014.
2. Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil 2003; 84: 736–746.
3. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29: 2365–2370.
4. Rauck R, Makumi CW, Schwartz S, Graff O, Meno-Tetang G, Bell CF et al. A Randomized, Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy. Pain Pract 2013; 13: 485–496.
5. Jensen MP, Friedman M, Bonzo D, Richards P. The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial. Clin J Pain 2006; 22: 97–103.
6. Valensi P, Le Devehat C, Richard JL, Farez C, Khodabandehlou T, Rosenbloom RA et al. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complications 2005; 19: 247–253.
7. Yuen KC, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 2002; 25: 1699–1703.
8. Swislocki A, Orth M, Bales M, Weisshaupt J, West C, Edrington J et al. A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Sympt Manage 2010; 39: 88–99.
9. Valk GD, Kappelle AC, Tjon ATAM, Bravenboer B, Bakker K, Michels RP et al. Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766. J Neurol 1996; 243: 257–263.
10. Farvid MS, Homayooni F. Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation. J Diabetes 2011; 3: 260.
11. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schutte K et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38: 1425–1433.
12. Ruhnau KJ, Meissner HP, Finn JR, Reljanovic M, Lobisch M, Schutte K et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 1999; 16: 1040–1043.
13. Campbell CM, Kipnes MS, Stouch BC, Brady KL, Kelly M, Schmidt WK et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012; 153: 1815–1823.
14. Lundborg GN, Bjorkman AC, Rosen BN, Nilsson JA, Dahlin LB. Cutaneous anaesthesia of the lower leg can improve sensibility in the diabetic foot. A double-blind, randomized clinical trial. Diabet Med 2010; 27: 823–829.
15. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 1235–1241.
16. Verhagen AP, de Vet HC, de Bie RA, Boers M, van den Brandt PA. The art of quality assessment of RCTs included in systematic reviews. J Clin Epidemiol 2001; 54: 651–654.
17. Clifft JK, Kasser RJ, Newton TS, Bush AJ. The effect of monochromatic infrared energy on sensation in patients with diabetic peripheral neuropathy: a double-blind, placebo-controlled study. Diabetes Care 2005; 28: 2896–2900.
18. Lavery LA, Murdoch DP, Williams J, Lavery DC. Does anodyne light therapy improve peripheral neuropathy in diabetes? A double-blind, sham-controlled, randomized trial to evaluate monochromatic infrared photoenergy. Diabetes Care 2008; 31: 316–321.
19. Dalal K, Maran VB, Pandey RM, Tripathi M. Determination of efficacy of reflexology in managing patients with diabetic neuropathy: a randomized controlled clinical trial. Evid Based Complement Alternat Med 2014; 2014: 843036.
20. Najafi B, Crews RT, Wrobel JS. A novel plantar stimulation technology for improving protective sensation and postural control in patients with diabetic peripheral neuropathy: a double-blinded, randomized study. Gerontology 2013; 59: 473–480.
21. Nawfar SA, Yacob NBM. Effects of monochromatic infrared energy therapy on diabetic feet with peripheral sensory neuropathy: a randomised controlled trial. Singap Med J 2011; 52: 669–672.
22. Ghasemi M, Ansari M, Basiri K, Shaigannejad V. The effects of intradermal botulinum toxin type A injections on pain symptoms of patients with diabetic neuropathy. J Res Med Sci 2014; 19: 106–111.
23. Chatchawan U, Eungpinichpong W, Plandee P, Yamauchi J. Effects of Thai foot massage on balance performance in diabetic patients with peripheral neuropathy: a randomized parallel-controlled trial. Med Sci Monit Basic Res 2015; 21: 68–75.
24. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26: 770–776.
25. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22: 1296–1301.
26. Akahori H, Takamura T, Hayakawa T, Ando H, Yamashita H, Kobayashi K. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality. Diabetes Res Clin Pract 2004; 64: 153–159.
27. Florkowski CM, Rowe BR, Nightingale S, Harvey TC, Barnett AH. Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy. Diabetes 1991; 40: 129–133.
28. Volchegorskii IA, Alekseev MN, Volchegorskaia MI, Rassokhina LM. Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome. Klin Med (Mosk) 2008; 86: 52–59.
29. Chen WT, Yuan RY, Chiang SC, Sheu JJ, Yu JM, Tseng IJ et al. OnabotulinumtoxinA Improves Tactile and Mechanical Pain Perception in Painful Diabetic Polyneuropathy. Clin J Pain 2013; 29: 305–310.
30. van Macare Maurik JF, Ter Horst B, van Hal M, Kon M, Peters EJ. Effect of surgical decompression of nerves in the lower extremity in patients with painful diabetic polyneuropathy on stability: A randomized controlled trial. Clin Rehabil 2015; 29: 994–1001.
31. Snedecor SJ, Sudharshan L, Cappelleri JC, Sadosky A, Mehta S, Botteman M. Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract 2014; 14: 167–184.
32. Han T, Bai J, Liu W, Hu Y. A systematic review and meta-analysis of alpha-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol 2012; 167: 465–471.
33. Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic Acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. Int J Endocrinol 2012; 2012: 456279.
34. McIlduff CE, Rutkove SB. Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. Ther Clin Risk Manag 2011; 7: 377–385.
35. Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011; 34: 2054–2060.
36. Griebeler ML, Tsapas A, Brito JP, Wang Z, Phung OJ, Montori VM et al. Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis (Protocol). Syst Rev 2012; 1: 61.
37. Campbell WW. Evaluation and management of peripheral nerve injury. Clin Neurophysiol 2008; 119: 1951–1965.